Exelixis Inc

NASDAQ:EXEL  
44.47
-0.40 (-0.89%)
7:43:36 PM EDT: $44.50 +0.03 (+0.07%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)12.13B
Current PE18.84
Forward PE 16.84
2yr Forward PE 14.16
See more stats
Estimates Current Quarter
Revenue$576.2 Million
Adjusted EPS$0.64
See more estimates
10-Day MA$44.55
50-Day MA$42.79
200-Day MA$36.49
See more pivots

Exelixis Inc Stock, NASDAQ:EXEL

1851 Harbor Bay Parkway, Alameda, California 94502
United States of America
Phone: +1.650.837.7000
Number of Employees: 1147

Description

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.